Pro-angiogenic factors such as the VEGF-A, bFGF, and MCP-1 are involved in the activation, mobilization and recruitment of EPCs from the bone marrow and in promoting the differentiation of EPCs into ECs in some ischemic diseases and during tumor growth [24,25]. This evidence concerns the gene CCL2 and neoplasm.